LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Ghosh, Debdatta"
  2. AU="Madheswaran, Suresh"
  3. AU=Rogerio Alexandre de Paula
  4. AU=Warshaw A L
  5. AU="Waqar Ahmed"
  6. AU="Harper, William A."
  7. AU="Fargo, Keith"
  8. AU=Reed Matthew J
  9. AU="Harris, Hannah L"
  10. AU="Asahi, Hiroko"
  11. AU="Mohamed El Mohadab"
  12. AU="Jamjoom, Maan"
  13. AU="Benjamin K. Harley"
  14. AU="Redpath, Stephanie"
  15. AU="Costa Oliveira, Diogo"
  16. AU="Ibarra-Meneses, Ana Victoria"
  17. AU=Ozgenel Guzin Yesim
  18. AU="Shu-Ying Li"
  19. AU="Umemura, Yutaka"
  20. AU=Eiring A M
  21. AU="Eunhee Ha"
  22. AU="Espíndola, Otávio M"
  23. AU=Shahbazian Heshmatollah
  24. AU="Esmaeel Panahi kokhdan"
  25. AU=Peekhaus N
  26. AU="Ferrari-Toniolo, Simone"
  27. AU="Oleg M. Mikhailenok"

Suchergebnis

Treffer 1 - 7 von insgesamt 7

Suchoptionen

  1. Artikel ; Online: Erythrocytic membrane anionic charge, sialic acid content, and their correlations with urinary glycosaminoglycans in preeclampsia and eclampsia.

    Sen, Papia / Ghosh, Debdatta / Sarkar, Chandan

    Scandinavian journal of clinical and laboratory investigation

    2020  Band 80, Heft 4, Seite(n) 343–347

    Abstract: Compared to healthy pregnant women, changes in erythrocytic membrane anionic charge (EAC) and urinary glycosaminoglycans ( ... ...

    Abstract Compared to healthy pregnant women, changes in erythrocytic membrane anionic charge (EAC) and urinary glycosaminoglycans (U
    Mesh-Begriff(e) Adult ; Case-Control Studies ; Eclampsia/diagnosis ; Eclampsia/urine ; Erythrocyte Membrane/chemistry ; Female ; Glycosaminoglycans/urine ; Humans ; Pre-Eclampsia/diagnosis ; Pre-Eclampsia/urine ; Pregnancy ; Proteoglycans/urine ; Sialic Acids/analysis ; Sialic Acids/chemistry ; Static Electricity
    Chemische Substanzen Glycosaminoglycans ; Proteoglycans ; Sialic Acids
    Sprache Englisch
    Erscheinungsdatum 2020-04-13
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 3150-1
    ISSN 1502-7686 ; 0036-5513
    ISSN (online) 1502-7686
    ISSN 0036-5513
    DOI 10.1080/00365513.2020.1750687
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Graphene oxide nanohybrids for electron transfer-mediated antimicrobial activity.

    Das, Nayan Mani / Singh, Amit Kumar / Ghosh, Debdatta / Bandyopadhyay, Dipankar

    Nanoscale advances

    2019  Band 1, Heft 9, Seite(n) 3727–3740

    Abstract: The rapid increase in the prevalence of antibiotic-resistant bacterial strains poses a global health risk. In this scenario, alternative strategies are needed to combat the alarming rise in multidrug-resistant bacterial populations. For example, metal- ... ...

    Abstract The rapid increase in the prevalence of antibiotic-resistant bacterial strains poses a global health risk. In this scenario, alternative strategies are needed to combat the alarming rise in multidrug-resistant bacterial populations. For example, metal-incorporated graphene derivatives have emerged as model nanomaterials owing to their intrinsic antibacterial activity together with their biocompatibility. Interestingly, photon-activated phthalocyanine sensitizers have also shown promising physiochemical biocidal effects against pathogenic bacteria populations when conjugated with diverse nanomaterials. Herein, we report the facile synthesis of graphene oxide incorporated zinc phthalocyanine (ZnPc-GO) nanohybrids showing bactericidal activity against Gram-negative
    Sprache Englisch
    Erscheinungsdatum 2019-08-15
    Erscheinungsland England
    Dokumenttyp Journal Article
    ISSN 2516-0230
    ISSN (online) 2516-0230
    DOI 10.1039/c9na00272c
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel: Aromatase inhibitors in recurrent ovarian endometriomas: report of five cases with literature review

    Seal, Subrata Lall / Kamilya, Gourisankar / Mukherji, Joydev / De, Alok / Ghosh, Debdatta / Majhi, Arup Kr

    Fertility and sterility. 2011 Jan., v. 95, no. 1

    2011  

    Abstract: OBJECTIVE: To determine the role of the aromatase inhibitor letrozole in the treatment of recurrent ovarian endometrioma cases. DESIGN: Nonrandomized proof of concept study. SETTINGS: Outpatient tertiary-care center. PATIENT(S): Five premenopausal ... ...

    Abstract OBJECTIVE: To determine the role of the aromatase inhibitor letrozole in the treatment of recurrent ovarian endometrioma cases. DESIGN: Nonrandomized proof of concept study. SETTINGS: Outpatient tertiary-care center. PATIENT(S): Five premenopausal patients with documented ovarian endometriomas and chronic pelvic pain, all of whome were previously treated with surgery and medicine with unsatisfactory results. INTERVENTION(S): Ovarian endometriomas were diagnosed by biopsy after laparoscopic ovarian cystectomy and subsequently treated with hormomes. After a 6-month washout of endometriosis hormone therapies, women took letrozole (2.5 mg), one tablet of 0.15 mg of desogestrel, and 0.03 mg of ethinyl estradiol, calcium (1,200 mg), and vitamin D₃ (800 IU) daily for 6 months. MAIN OUTCOME MEASURE(S): Size of endometriomas (monitored by ultrasound), assessment of pelvic pain (by visual analog scale), and bone density (DEXA scan). RESULT(S): Disappearance of ovarian endometrioma and reduction in pelvic pain in all cases at the end of 6 months. The size of ovarian endometriomas was reduced after 3 months. Pain scores decreased only after 1 month of treatment and continued decreasing in each treatment month. Overall, no significant change in bone density was detected. CONCLUSION(S): Letrozole given with combined pills achieved complete regression of recurrent endometriotic cysts and pain relief in all cases.
    Schlagwörter analgesia ; animal ovaries ; biopsy ; bone density ; calcium ; cholecalciferol ; dual-energy X-ray absorptiometry ; estradiol ; medicine ; pain ; patients ; premenopause ; ultrasonics ; unspecific monooxygenase ; women
    Sprache Englisch
    Erscheinungsverlauf 2011-01
    Umfang p. 291.e15-291.e18.
    Erscheinungsort Elsevier Inc.
    Dokumenttyp Artikel
    ZDB-ID 80133-1
    ISSN 1556-5653 ; 0015-0282
    ISSN (online) 1556-5653
    ISSN 0015-0282
    DOI 10.1016/j.fertnstert.2010.05.021
    Datenquelle NAL Katalog (AGRICOLA)

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Aromatase inhibitors in recurrent ovarian endometriomas: report of five cases with literature review.

    Lall Seal, Subrata / Kamilya, Gourisankar / Mukherji, Joydev / De, Alok / Ghosh, Debdatta / Majhi, Arup Kr

    Fertility and sterility

    2011  Band 95, Heft 1, Seite(n) 291.e15–8

    Abstract: Objective: To determine the role of the aromatase inhibitor letrozole in the treatment of recurrent ovarian endometrioma cases.: Design: Nonrandomized proof of concept study.: Settings: Outpatient tertiary-care center.: Patient(s): Five ... ...

    Abstract Objective: To determine the role of the aromatase inhibitor letrozole in the treatment of recurrent ovarian endometrioma cases.
    Design: Nonrandomized proof of concept study.
    Settings: Outpatient tertiary-care center.
    Patient(s): Five premenopausal patients with documented ovarian endometriomas and chronic pelvic pain, all of whom were previously treated with surgery and medicine with unsatisfactory results.
    Intervention(s): Ovarian endometriomas were diagnosed by biopsy after laparoscopic ovarian cystectomy and subsequently treated with hormones. After a 6-month washout of endometriosis hormone therapies, women took letrozole (2.5 mg), one tablet of 0.15 mg of desogestrel, and 0.03 mg of ethinyl estradiol, calcium (1,200 mg), and vitamin D3 (800 IU) daily for 6 months.
    Main outcome measure(s): Size of endometriomas (monitored by ultrasound), assessment of pelvic pain (by visual analog scale), and bone density (DEXA scan).
    Result(s): Disappearance of ovarian endometrioma and reduction in pelvic pain in all cases at the end of 6 months. The size of ovarian endometriomas was reduced after 3 months. Pain scores decreased only after 1 month of treatment and continued decreasing in each treatment month. Overall, no significant change in bone density was detected.
    Conclusion(s): Letrozole given with combined pills achieved complete regression of recurrent endometriotic cysts and pain relief in all cases.
    Mesh-Begriff(e) Adult ; Aromatase Inhibitors/therapeutic use ; Endometriosis/drug therapy ; Female ; Humans ; Nitriles/therapeutic use ; Remission Induction ; Triazoles/therapeutic use
    Chemische Substanzen Aromatase Inhibitors ; Nitriles ; Triazoles ; letrozole (7LKK855W8I)
    Sprache Englisch
    Erscheinungsdatum 2011-01
    Erscheinungsland United States
    Dokumenttyp Case Reports ; Journal Article ; Review
    ZDB-ID 80133-1
    ISSN 1556-5653 ; 0015-0282
    ISSN (online) 1556-5653
    ISSN 0015-0282
    DOI 10.1016/j.fertnstert.2010.05.021
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel: Malignant mixed mullerian tumour of the fallopian tube of heterologous variety--a case report.

    Das, Tushar Kanti / Raha, Kalpana / Bandyopadhyay, Anjali / Dasgupta, Anjali / Ghosh, Debdatta / Mondal, Ashoke Kumar

    Indian journal of pathology & microbiology

    2005  Band 48, Heft 3, Seite(n) 354–356

    Abstract: A female aged 49 years presented with pain and progressive swelling of right lower abdomen. She was operated upon and gross examination revealed a proliferative growth in the fimbrial end of the right fallopian tube. Microscopically the tumour comprised ... ...

    Abstract A female aged 49 years presented with pain and progressive swelling of right lower abdomen. She was operated upon and gross examination revealed a proliferative growth in the fimbrial end of the right fallopian tube. Microscopically the tumour comprised of adenocarcinoma and component of spindle cell stromal sarcoma with areas of chondrosarcoma as heterologous element. A diagnosis of malignant mixed mullerian tumour of the fallopian tube, clinically FIGO stage III was made, which is extremely rare in available literature.
    Mesh-Begriff(e) Adenocarcinoma/pathology ; Fallopian Tube Neoplasms/pathology ; Fallopian Tubes/pathology ; Female ; Humans ; Middle Aged ; Mixed Tumor, Malignant/pathology ; Mixed Tumor, Mullerian/pathology ; Sarcoma/pathology
    Sprache Englisch
    Erscheinungsdatum 2005-07
    Erscheinungsland India
    Dokumenttyp Case Reports ; Journal Article
    ZDB-ID 197621-7
    ISSN 0974-5130 ; 0377-4929
    ISSN (online) 0974-5130
    ISSN 0377-4929
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel: Availability and use of emergency obstetric care services in four districts of West Bengal, India.

    Biswas, Akhil Bandhu / Das, Dilip Kumar / Misra, Raghunath / Roy, Rabindra Nath / Ghosh, Debdatta / Mitra, Kaninika

    Journal of health, population, and nutrition

    2005  Band 23, Heft 3, Seite(n) 266–274

    Abstract: Process indicators have been recommended for monitoring the availability and use of emergency obstetric care (EmOC) services. A health facility-based study was carried out in 2002 in four districts of West Bengal, India, to analyze these process ... ...

    Abstract Process indicators have been recommended for monitoring the availability and use of emergency obstetric care (EmOC) services. A health facility-based study was carried out in 2002 in four districts of West Bengal, India, to analyze these process indicators. Relevant records and registers for 2001 of all studied facilities in the districts were reviewed to collect data using a pre-designed schedule. The numbers of basic and comprehensive EmOC facilities were inadequate in all the four districts compared to the minimum acceptable level. Overall, 26.2% of estimated annual births took place in the EmOC facilities (ranged from 16.2% to 45.8% in 4 districts) against the required minimum of 15%. The rate of caesarean section calculated for all expected births in the population varied from 3.5% to 4.4% in the four districts with an overall rate of 4%, which is less than the minimum target of 5%. Only 29.9% of the estimated number of complications (which is 15% of all births) was managed in the EmOC facilities. The combined case-fatality rate in the basic/comprehensive EmOC facilities was 1.7%. Major obstetric complications contributed to 85.7% of maternal deaths, and pre-eclampsia/eclampsia was the most common cause. It can be concluded that all the process indicators, except proportion of deliveries in the EmOC facilities, were below the acceptable level. Certain priority measures, such as making facilities fully functional, effective referral and monitoring system, skill-based training, etc., are to be emphasized to improve the situation.
    Mesh-Begriff(e) Cesarean Section/statistics & numerical data ; Critical Care/methods ; Delivery, Obstetric/mortality ; Emergency Medical Services/utilization ; Female ; Humans ; India ; Maternal Health Services/standards ; Obstetric Labor Complications ; Pregnancy ; Pregnancy Complications/mortality ; Pregnancy Outcome
    Sprache Englisch
    Erscheinungsdatum 2005-09
    Erscheinungsland Bangladesh
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2025045-9
    ISSN 2072-1315 ; 1606-0997
    ISSN (online) 2072-1315
    ISSN 1606-0997
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel: Aromatase inhibitors in recurrent ovarian endometriomas: report of five cases with literature review

    Seal, Subrata Lall / Kamilya, Gourisankar / Mukherji, Joydev / De, Alok / Ghosh, Debdatta / Majhi, Arup Kr.

    Fertility and sterility

    Band v. 95,, Heft no. 1

    Abstract: OBJECTIVE: To determine the role of the aromatase inhibitor letrozole in the treatment of recurrent ovarian endometrioma cases. DESIGN: Nonrandomized proof of concept study. SETTINGS: Outpatient tertiary-care center. PATIENT(S): Five premenopausal ... ...

    Abstract OBJECTIVE: To determine the role of the aromatase inhibitor letrozole in the treatment of recurrent ovarian endometrioma cases. DESIGN: Nonrandomized proof of concept study. SETTINGS: Outpatient tertiary-care center. PATIENT(S): Five premenopausal patients with documented ovarian endometriomas and chronic pelvic pain, all of whome were previously treated with surgery and medicine with unsatisfactory results. INTERVENTION(S): Ovarian endometriomas were diagnosed by biopsy after laparoscopic ovarian cystectomy and subsequently treated with hormomes. After a 6-month washout of endometriosis hormone therapies, women took letrozole (2.5 mg), one tablet of 0.15 mg of desogestrel, and 0.03 mg of ethinyl estradiol, calcium (1,200 mg), and vitamin D₃ (800 IU) daily for 6 months. MAIN OUTCOME MEASURE(S): Size of endometriomas (monitored by ultrasound), assessment of pelvic pain (by visual analog scale), and bone density (DEXA scan). RESULT(S): Disappearance of ovarian endometrioma and reduction in pelvic pain in all cases at the end of 6 months. The size of ovarian endometriomas was reduced after 3 months. Pain scores decreased only after 1 month of treatment and continued decreasing in each treatment month. Overall, no significant change in bone density was detected. CONCLUSION(S): Letrozole given with combined pills achieved complete regression of recurrent endometriotic cysts and pain relief in all cases.
    Schlagwörter unspecific monooxygenase ; calcium ; biopsy ; premenopause ; pain ; analgesia ; dual-energy X-ray absorptiometry ; women ; animal ovaries ; cholecalciferol ; patients ; bone density ; medicine ; estradiol ; ultrasonics
    Sprache Englisch
    Dokumenttyp Artikel
    ISSN 0015-0282
    Datenquelle AGRIS - International Information System for the Agricultural Sciences and Technology

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang